| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/15/2011 | EP2332547A1 Tetracyclines for the treatment of inflammatory bowel disease |
| 06/15/2011 | EP2332546A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332542A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors |
| 06/15/2011 | EP2332541A1 Use of thioxanthine derivatives as MPO inhibitors |
| 06/15/2011 | EP2332531A1 Apo2 ligand/TRAIL formulations |
| 06/15/2011 | EP2331708A1 Tbc1d7 as tumor marker and therapeutic target for cancer |
| 06/15/2011 | EP2331563A1 Peptidic and peptidomimetic compounds for regulating autophagy |
| 06/15/2011 | EP2331555A1 Ferrocene derivatives having antineoplastic activity |
| 06/15/2011 | EP2331547A1 Pyrrolopyrimidine compounds as cdk inhibitors |
| 06/15/2011 | EP2331546A1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof |
| 06/15/2011 | EP2331544A1 2-amino pyrimidine compounds as potent hsp-90 inhibitors |
| 06/15/2011 | EP2331543A1 3-deazaneplanocin derivatives |
| 06/15/2011 | EP2331537A1 Organic compounds |
| 06/15/2011 | EP2331530A2 Fused multicyclic compounds as protein kinase inhibitors |
| 06/15/2011 | EP2331526A2 Pyrimidine derivatives as kinase inhibitors |
| 06/15/2011 | EP2331525A2 Halofuginone analogs for inhibition of trna synthetases and uses thereof |
| 06/15/2011 | EP2331523A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
| 06/15/2011 | EP2331520A1 Rosamine derivatives as agents for the treatment of cancer |
| 06/15/2011 | EP2331514A2 Cyclic polyamines for binding phosphatidylserine |
| 06/15/2011 | EP2331501A1 Small molecule inhibitors of n-terminus activation of the androgen receptor |
| 06/15/2011 | EP2331497A1 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof |
| 06/15/2011 | EP2331142A2 Use of a truncated elf-5a1 polynucleotide to induce apoptosis in cancer cells |
| 06/15/2011 | EP2331140A1 Multi-arm polymeric alkanoate conjugates |
| 06/15/2011 | EP2331136A2 Frizzled-binding agents and uses thereof |
| 06/15/2011 | EP2331131A1 Treating cancer by modulating rna helicases |
| 06/15/2011 | EP2331129A1 Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 06/15/2011 | EP2331118A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 06/15/2011 | EP2331115A2 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs |
| 06/15/2011 | EP2331109A1 Methods and compositions for treatment of bone defects with placental cell populations |
| 06/15/2011 | EP2331107A1 Vhz for diagnosis and treatment of cancers |
| 06/15/2011 | EP2331103A1 Nuclear factor kappa b pathway inhibitor composition and use of same |
| 06/15/2011 | EP2331096A1 Dabigatran in tumour therapy |
| 06/15/2011 | EP2331092A2 Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer |
| 06/15/2011 | EP2331091A1 Pharmaceutical combination of 1-(2-tetrahydrofuryl)-5-fluorouracil and caffeic acid phenethyl ester for oral treating of tumors |
| 06/15/2011 | EP2330909A1 Chemical compounds |
| 06/15/2011 | EP2330901A1 Treatment for leukemia and idiopathic aplastic anemia |
| 06/15/2011 | EP2187878B1 Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| 06/15/2011 | EP2007769B1 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof |
| 06/15/2011 | EP1937650B1 Heterocyclic compounds |
| 06/15/2011 | EP1899346B1 Pyrrolotriazine compounds useful as kinase inhibitors |
| 06/15/2011 | EP1842921B1 Recombined adenovirus p53 preparation for treating tumor |
| 06/15/2011 | EP1838718B1 Pyrrolopyrazoles, potent kinase inhibitors |
| 06/15/2011 | EP1784399B1 Pyrimidine derivatives |
| 06/15/2011 | EP1717229B1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein |
| 06/15/2011 | EP1699480B1 Allogeneic tumor therapeutic agent |
| 06/15/2011 | EP1622616B1 Inhibitors of akt activity |
| 06/15/2011 | EP1578751B1 Pyrrolopyrimidine derivatives |
| 06/15/2011 | EP1417229B1 Methods and compounds for the targeting of protein to exosomes |
| 06/15/2011 | EP1349558B1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 06/15/2011 | EP1330456B1 N8,n13 -disubstituted quino[4,3,2-kl]acridinium salts as therapeutic agents |
| 06/15/2011 | CN1995056B Curcumenol glucoside compound and its preparation method and uses |
| 06/15/2011 | CN1943647B The method for preparing triterpenic acid extract from the loquat leaves |
| 06/15/2011 | CN1865275B Artificial single-chain deoxynucleotide having therapeutic effect to human B cell tumour |
| 06/15/2011 | CN1849135B Methods for treating interleukin-6-related diseases |
| 06/15/2011 | CN1830964B 4-Substituting anilino-3-nitroquinoline compounds, prepn. method and use thereof |
| 06/15/2011 | CN1820734B Treatment with anti-erbb2 antibodies |
| 06/15/2011 | CN1700923B Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 06/15/2011 | CN1452636B Human monoclonal antibodies to dendritis cells |
| 06/15/2011 | CN102099472A Nucleic acid molecule and method of targeting gene expression to gliomas |
| 06/15/2011 | CN102099471A Aptamer against il-17 and use thereof |
| 06/15/2011 | CN102099468A Anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 06/15/2011 | CN102099467A SiRNA of human osteopontin |
| 06/15/2011 | CN102099378A Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same |
| 06/15/2011 | CN102099377A CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 06/15/2011 | CN102099374A Methods and compositions for modulating angiogenesis and pericyte composition |
| 06/15/2011 | CN102099367A Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 06/15/2011 | CN102099358A Compound with serotoninergic activity, process for preparing same and pharmaceutical composition comprising same |
| 06/15/2011 | CN102099352A STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 06/15/2011 | CN102099336A Novel phenylamino isonicotinamide compounds |
| 06/15/2011 | CN102099040A Pregesteron antagonists such as cdb-4124 in the treatment of breast cancer |
| 06/15/2011 | CN102099038A Materials and methods for suppressing and/or treating neurofibroma and related tumors |
| 06/15/2011 | CN102099034A Antineoplastic combinations containing HKI-272 and vinorelbine |
| 06/15/2011 | CN102099025A Combination therapy with an antitumor alkaloid |
| 06/15/2011 | CN102099021A Use of hdac inhibitors for the treatment of hodgkin's disease |
| 06/15/2011 | CN102094042A Recombinant vector of ZNF300 gene and application thereof |
| 06/15/2011 | CN102094020A RNA (Ribose Nucleic Acid) interference sequence and recombined interference plasmid for inhibiting fucosyltransferase I synthesized by LeY carbohydrate antigens |
| 06/15/2011 | CN102094019A RNA (Ribose Nucleic Acid) interference sequence and recombined interference plasmid for inhibiting fucosyltransferase IV synthesized by LeY carbohydrate antigens |
| 06/15/2011 | CN102093598A Composite edible fungi polysaccharides and preparation method thereof |
| 06/15/2011 | CN102093479A Recombinant chimeric antibody of anti-human vascular endothelium growth factor receptor 2 |
| 06/15/2011 | CN102093460A Triterpenoid saponin compound as well as synthesis method and application of triterpenoid saponin |
| 06/15/2011 | CN102093459A Penthorum chinense pursh extract and preparation method and application thereof |
| 06/15/2011 | CN102093455A 16-substituted-3heterocycle-5alpha androstane derivative, and preparation method and application thereof |
| 06/15/2011 | CN102093452A Hydrogenation type ginsenoside aglycons as well as preparation method and application of hydrogenation type ginsenoside aglycons |
| 06/15/2011 | CN102093431A Organotin-oxygen cluster containing ferrocene pyrazole and application of cluster |
| 06/15/2011 | CN102093424A Platinum coordination compound of anti-tumor medicaments |
| 06/15/2011 | CN102093421A Phosphorus substituent group-containing quinoline compound and preparation method of quinoline compound as well as pharmaceutical composition containing quinoline compound and application of pharmaceutical composition |
| 06/15/2011 | CN102093383A Potassium cantharidate and preparation method thereof |
| 06/15/2011 | CN102093381A 6H-benzofuran[3,2-c][1]benzopryan-6-ketone compound as well as preparation method and application of 6H-benzofuran[3,2-c][1] benzopryan-6-ketone compound |
| 06/15/2011 | CN102093376A Furocoumarin compound and application thereof |
| 06/15/2011 | CN102093370A Spirosthydroxyindole heterocyclic compounds and preparation method and use thereof |
| 06/15/2011 | CN102093364A 2,4-diamido-6,7-dihydro-5H-pyrrolo [2,3] pyrimidine derivative as focal adhesion kinase/pyruvate kinase 2 (FAK/Pyk2) inhibitor |
| 06/15/2011 | CN102093353A 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 06/15/2011 | CN102093347A 1,3,6-trisubstituted-beta-carboline cyclin-dependent kinase 2 inhibitor and application thereof |
| 06/15/2011 | CN102093340A Preparation method and application of 2-methylindazole derivatives |
| 06/15/2011 | CN102093339A Preparation method and application of pyrimidine derivatives |
| 06/15/2011 | CN102093315A C7 and C10 modified 1-dehydroxyl taxol analogue and preparation method thereof |
| 06/15/2011 | CN102093274A Chalcone-containing acylthiourea compounds and preparation method and use thereof |
| 06/15/2011 | CN102093258A Aromatic diamidine compound and synthesis method thereof |
| 06/15/2011 | CN102093191A Resveratrol chalcone derivative and preparation method thereof |
| 06/15/2011 | CN102093187A Polyketone compounds and application thereof |